Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer
about
From bench to bedside: immunotherapy for prostate cancerThe many faces of neuroendocrine differentiation in prostate cancer progressionCombination of the PI3K inhibitor ZSTK474 with a PSMA-targeted immunotoxin accelerates apoptosis and regression of prostate cancerReal-World Corticosteroid Utilization Patterns in Patients with Metastatic Castration-Resistant Prostate Cancer in 2 Large US Administrative Claims Databases.Cullin-1 promotes cell proliferation via cell cycle regulation and is a novel in prostate cancer.Clusterin Seals the Ocular Surface Barrier in Mouse Dry Eye.Patient preferences for treatment of castration-resistant prostate cancer in Japan: a discrete-choice experiment.The hurdle of antiandrogen drug resistance: drug design strategies.Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level.The treatment patterns of castration-resistant prostate cancer in Japan, including symptomatic skeletal events and associated treatment and healthcare resource use.Serum tri- and tetra-antennary N-glycan is a potential predictive biomarker for castration-resistant prostate cancer.Global advances in prostate cancer diagnosis and therapy.
P2860
Q26864390-7CE4C784-34D7-49DB-A9AF-3B77E4D3086CQ26992049-FD7780FF-607E-459D-ADF1-833438509848Q30557008-B591C87F-FBC3-4972-A937-D7D24A00CD68Q33652859-8624C583-1254-4087-9C07-6A878122DF10Q34043994-7CD8A1F5-70F8-493E-BB58-7605CB1BB344Q35786703-5056B32C-BFB8-4D91-BC7C-D017E6E16F9FQ36183227-DB3AA1CB-0AB5-4BF2-9FA6-494C410CEC53Q38160927-E9FAED45-8197-427B-B459-4AAA53CA165FQ38259197-6789A978-A87B-41EF-8679-B51FC8F2CC7CQ38917844-57136678-235D-4674-B800-341198A833E7Q38963035-0897ABD9-F2B7-4DE4-81F3-A76284B219B5Q42548875-DC20D452-CD04-4698-980E-005306CCF15D
P2860
Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer
@ast
Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer
@en
Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer
@nl
type
label
Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer
@ast
Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer
@en
Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer
@nl
prefLabel
Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer
@ast
Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer
@en
Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer
@nl
P2860
P3181
P356
P1476
Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer
@en
P2093
Martin E Gleave
Paul J Toren
P2860
P3181
P356
10.1038/AJA.2013.38
P407
P577
2013-05-01T00:00:00Z